The need for accurate quantitation of CMV and EBV in the management of transplant patients

In the United States, over 40,000 transplantations are performed annually. Ensuring post-transplant success requires diligent monitoring of infectious diseases that are associated with a wide range of pathology including organ graft failure and death. CMV and EBV are opportunistic viruses with high prevalence. Infections from these viruses can be asymptomatic or in some cases may cause mild symptoms in immunocompetent individuals but can lead to significant complications in those who are immunocompromised e.g. patients post-transplant. For this reason, post-transplantation monitoring of CMV and EBV viral load plays an important role in the management of transplant recipients.

 

Learning Objectives